N-(3-(5-(2,4,5-trifluoro-3-hydroxybenzoyl)thiophen-2-yl)phenyl)-2-(trifluoromethoxy)benzenesulfonamide

ID: ALA4285743

PubChem CID: 122652951

Max Phase: Preclinical

Molecular Formula: C24H13F6NO5S2

Molecular Weight: 573.49

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(c1ccc(-c2cccc(NS(=O)(=O)c3ccccc3OC(F)(F)F)c2)s1)c1cc(F)c(F)c(O)c1F

Standard InChI:  InChI=1S/C24H13F6NO5S2/c25-15-11-14(20(26)23(33)21(15)27)22(32)18-9-8-17(37-18)12-4-3-5-13(10-12)31-38(34,35)19-7-2-1-6-16(19)36-24(28,29)30/h1-11,31,33H

Standard InChI Key:  RKOXKEAQCMCSPB-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 38 41  0  0  0  0  0  0  0  0999 V2000
    9.6825   -7.1566    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.8653   -7.1566    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    9.2739   -7.8643    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1040   -2.6331    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1028   -3.4527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8109   -3.8616    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5205   -3.4522    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5177   -2.6295    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8091   -2.2243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2239   -2.2183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9331   -2.6242    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2208   -1.4011    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.0207   -3.4360    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    8.8207   -3.6029    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2267   -2.8936    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6775   -2.2885    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1559   -4.3482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6751   -5.0076    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0097   -5.7523    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8235   -5.8352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3017   -5.1673    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9645   -4.4252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8066   -1.4071    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.8107   -4.6788    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.3948   -3.8607    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.3962   -2.2247    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.5315   -6.4150    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.3882   -7.8231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5766   -7.7361    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0986   -8.3980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4334   -9.1444    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2509   -9.2250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7253   -8.5621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2440   -6.9897    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.4312   -6.9046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0986   -6.1582    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.9511   -7.5659    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.6130   -6.9007    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  8 10  1  0
 10 11  1  0
 10 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 11  2  0
 14 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
  9 23  1  0
  6 24  1  0
  5 25  1  0
  4 26  1  0
 19 27  1  0
 27  2  1  0
  2 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 28  1  0
 29 34  1  0
 34 35  1  0
 35 36  1  0
 35 37  1  0
 35 38  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4285743

    ---

Associated Targets(Human)

HSD17B2 Tchem Estradiol 17-beta-dehydrogenase 2 (1671 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HSD17B1 Tchem Estradiol 17-beta-dehydrogenase 1 (2224 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HEK293 (82097 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AHR Tclin Aryl hydrocarbon receptor (1071 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NR1I2 Tchem Pregnane X receptor (6667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NR1I3 Tchem Nuclear receptor subfamily 1 group I member 3 (655 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ESR1 Tclin Estrogen receptor alpha (17718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ESR2 Tclin Estrogen receptor beta (9272 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Hsd17b2 Estradiol 17-beta-dehydrogenase 2 (138 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hsd17b1 Estradiol 17-beta-dehydrogenase 1 (138 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 573.49Molecular Weight (Monoisotopic): 573.0139AlogP: 6.47#Rotatable Bonds: 7
Polar Surface Area: 92.70Molecular Species: ACIDHBA: 6HBD: 2
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 6.10CX Basic pKa: CX LogP: 7.03CX LogD: 5.37
Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.15Np Likeness Score: -1.37

References

1. Siebenbuerger L, Hernandez-Olmos V, Abdelsamie AS, Frotscher M, van Koppen CJ, Marchais-Oberwinkler S, Scheuer C, Laschke MW, Menger MD, Boerger C, Hartmann RW..  (2018)  Highly Potent 17β-HSD2 Inhibitors with a Promising Pharmacokinetic Profile for Targeted Osteoporosis Therapy.,  61  (23): [PMID:30480443] [10.1021/acs.jmedchem.8b01373]
2. Abdelsamie AS, Salah M, Siebenbürger L, Merabet A, Scheuer C, Frotscher M, Müller ST, Zierau O, Vollmer G, Menger MD, Laschke MW, van Koppen CJ, Marchais-Oberwinkler S, Hartmann RW..  (2019)  Design, Synthesis, and Biological Characterization of Orally Active 17β-Hydroxysteroid Dehydrogenase Type 2 Inhibitors Targeting the Prevention of Osteoporosis.,  62  (15): [PMID:31343176] [10.1021/acs.jmedchem.9b00932]
3. Abdelsamie AS, Salah M, Siebenbürger L, Hamed MM, Börger C, van Koppen CJ, Frotscher M, Hartmann RW..  (2019)  Development of potential preclinical candidates with promising in vitro ADME profile for the inhibition of type 1 and type 2 17β-Hydroxysteroid dehydrogenases: Design, synthesis, and biological evaluation.,  178  [PMID:31176098] [10.1016/j.ejmech.2019.05.084]
4. Abdelsamie AS, Herath S, Biskupek Y, Börger C, Siebenbürger L, Salah M, Scheuer C, Marchais-Oberwinkler S, Frotscher M, Pohlemann T, Menger MD, Hartmann RW, Laschke MW, van Koppen CJ..  (2019)  Targeted Endocrine Therapy: Design, Synthesis, and Proof-of-Principle of 17β-Hydroxysteroid Dehydrogenase Type 2 Inhibitors in Bone Fracture Healing.,  62  (3): [PMID:30645111] [10.1021/acs.jmedchem.8b01493]

Source